Wallin R, Patrick S D, Martin L F
Department of Physiology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Biochem Pharmacol. 1987 Dec 15;36(24):4303-6. doi: 10.1016/0006-2952(87)90675-7.
The effect of 3-methylcholanthrene on liver enzymes in the vitamin K-dependent carboxylation system has been investigated in normal rats and rats treated with the anticoagulant warfarin. It was found that 3-methylcholanthrene did not interfere with the anticoagulant function of the drug. Treatment of rats with 3-methylcholanthrene resulted in a 2.7-fold increase in liver cytosolic DT-diaphorase activity and a 1.5-fold increase in liver microsomal vitamin K-dependent carboxylase activity. A pathway for production of reduced vitamin K cofactor for the vitamin K-dependent carboxylase is catalyzed by DT-diaphorase and an as yet unidentified NADH-specific dehydrogenase(s). The data suggest that the unidentified enzyme(s) in the pathway is not induced by 3-methylcholanthrene.
在正常大鼠和用抗凝剂华法林治疗的大鼠中,研究了3-甲基胆蒽对维生素K依赖羧化系统中肝脏酶的影响。发现3-甲基胆蒽不干扰该药物的抗凝功能。用3-甲基胆蒽处理大鼠导致肝脏胞质DT-黄递酶活性增加2.7倍,肝脏微粒体维生素K依赖羧化酶活性增加1.5倍。DT-黄递酶和一种尚未鉴定的NADH特异性脱氢酶催化了维生素K依赖羧化酶还原型维生素K辅因子的产生途径。数据表明该途径中未鉴定的酶不受3-甲基胆蒽诱导。